ZA957025B - Process for the preparation of the (-)-N-methyl-N-(4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl) benzamide and its pharmaceutically acceptable salts - Google Patents
Process for the preparation of the (-)-N-methyl-N-(4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl) benzamide and its pharmaceutically acceptable saltsInfo
- Publication number
- ZA957025B ZA957025B ZA957025A ZA957025A ZA957025B ZA 957025 B ZA957025 B ZA 957025B ZA 957025 A ZA957025 A ZA 957025A ZA 957025 A ZA957025 A ZA 957025A ZA 957025 B ZA957025 B ZA 957025B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- benzamide
- dichlorophenyl
- phenyl
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
- C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/41—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by carboxyl groups, other than cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/294,035 US5512680A (en) | 1993-02-26 | 1994-08-24 | Process for the preparation of an optically pure aminoalcohol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA957025B true ZA957025B (en) | 1996-03-26 |
Family
ID=23131621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA957025A ZA957025B (en) | 1994-08-24 | 1995-08-22 | Process for the preparation of the (-)-N-methyl-N-(4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl) benzamide and its pharmaceutically acceptable salts |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5512680A (fi) |
| EP (1) | EP0698601B1 (fi) |
| JP (1) | JP3037592B2 (fi) |
| KR (1) | KR100275978B1 (fi) |
| AT (1) | ATE172964T1 (fi) |
| AU (1) | AU685971B2 (fi) |
| BR (1) | BR9503776A (fi) |
| CA (1) | CA2156764C (fi) |
| CZ (1) | CZ289654B6 (fi) |
| DE (1) | DE69505756T2 (fi) |
| DK (1) | DK0698601T3 (fi) |
| ES (1) | ES2125574T3 (fi) |
| FI (1) | FI116221B (fi) |
| HU (1) | HU218485B (fi) |
| IL (1) | IL114866A (fi) |
| MY (1) | MY116365A (fi) |
| NO (1) | NO305167B1 (fi) |
| NZ (1) | NZ272827A (fi) |
| PL (1) | PL182914B1 (fi) |
| RU (1) | RU2097376C1 (fi) |
| SI (1) | SI0698601T1 (fi) |
| SK (1) | SK281454B6 (fi) |
| TW (1) | TW410223B (fi) |
| ZA (1) | ZA957025B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2792835B3 (fr) * | 1999-04-27 | 2001-05-25 | Sanofi Sa | Utilisation du saredutant pour la preparation de medicaments utiles dans le traitement ou la prevention de l'ensemble des troubles de l'humeur, des troubles de l'adaptation ou des troubles mixtes anxiete-depression |
| WO2007020079A2 (en) * | 2005-08-17 | 2007-02-22 | Synthon B.V. | Orally disintegratable simvastatin tablets |
| JP2009191006A (ja) * | 2008-02-14 | 2009-08-27 | Sumitomo Chemical Co Ltd | 光学活性な４−アミノ−３−（３，４−ジクロロフェニル）ブタン−１−オールの製造方法およびその中間体 |
| EP3322691A4 (en) | 2015-07-13 | 2019-03-27 | Piramal Enterprises Limited | IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE903957A1 (en) * | 1989-11-06 | 1991-05-08 | Sanofi Sa | Aromatic amine compounds, their method of preparation and¹pharmaceutical compositions in which they are present |
| IL99320A (en) * | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| FR2676054B1 (fr) | 1991-05-03 | 1993-09-03 | Sanofi Elf | Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2688219B1 (fr) | 1992-03-03 | 1994-07-08 | Sanofi Elf | Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant. |
| US5391819A (en) * | 1992-09-30 | 1995-02-21 | Merck & Co., Inc. | Process of making chiral 2-aryl-1,4-butanediamine derivatives as useful neurokinin-A antagonists |
| FR2701946B1 (fr) * | 1993-02-26 | 1995-05-24 | Sanofi Elf | Procédé pour la préparation d'un aminoalcool optiquement pur. |
-
1994
- 1994-08-24 US US08/294,035 patent/US5512680A/en not_active Expired - Lifetime
-
1995
- 1995-08-08 IL IL11486695A patent/IL114866A/xx not_active IP Right Cessation
- 1995-08-16 MY MYPI95002400A patent/MY116365A/en unknown
- 1995-08-22 ZA ZA957025A patent/ZA957025B/xx unknown
- 1995-08-22 NZ NZ272827A patent/NZ272827A/en not_active IP Right Cessation
- 1995-08-22 SK SK1030-95A patent/SK281454B6/sk not_active IP Right Cessation
- 1995-08-23 EP EP95401935A patent/EP0698601B1/en not_active Expired - Lifetime
- 1995-08-23 RU RU95114391/04A patent/RU2097376C1/ru not_active IP Right Cessation
- 1995-08-23 KR KR1019950026201A patent/KR100275978B1/ko not_active IP Right Cessation
- 1995-08-23 DK DK95401935T patent/DK0698601T3/da active
- 1995-08-23 CA CA002156764A patent/CA2156764C/en not_active Expired - Lifetime
- 1995-08-23 BR BR9503776A patent/BR9503776A/pt not_active Application Discontinuation
- 1995-08-23 CZ CZ19952164A patent/CZ289654B6/cs not_active IP Right Cessation
- 1995-08-23 AT AT95401935T patent/ATE172964T1/de active
- 1995-08-23 ES ES95401935T patent/ES2125574T3/es not_active Expired - Lifetime
- 1995-08-23 SI SI9530196T patent/SI0698601T1/xx not_active IP Right Cessation
- 1995-08-23 DE DE69505756T patent/DE69505756T2/de not_active Expired - Lifetime
- 1995-08-23 AU AU30216/95A patent/AU685971B2/en not_active Ceased
- 1995-08-23 NO NO953313A patent/NO305167B1/no not_active IP Right Cessation
- 1995-08-24 PL PL95310155A patent/PL182914B1/pl not_active IP Right Cessation
- 1995-08-24 JP JP7216328A patent/JP3037592B2/ja not_active Expired - Fee Related
- 1995-08-24 FI FI953994A patent/FI116221B/fi not_active IP Right Cessation
- 1995-08-24 HU HU9502481A patent/HU218485B/hu not_active IP Right Cessation
- 1995-08-31 TW TW084109104A patent/TW410223B/zh not_active IP Right Cessation
-
1996
- 1996-02-07 US US08/598,001 patent/US5780666A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT59109A (en) | Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same | |
| MY115679A (en) | Process for preparing intermediates to florfenicol | |
| ZA957025B (en) | Process for the preparation of the (-)-N-methyl-N-(4-(4-phenyl-4-acetylaminopiperidin-1-yl)-2-(3,4-dichlorophenyl)butyl) benzamide and its pharmaceutically acceptable salts | |
| TW247311B (fi) | ||
| MY130190A (en) | Method for the preparation of 4-halo-2'- nitrobutyrophenone compounds | |
| HUT71513A (en) | 2-substituted-(3-chlorophenyl)-3,6-diazahexanoic acid derivatives for producing alkil-trazodone derivatives and process for producing them | |
| AU2532692A (en) | Method for treating hypertension | |
| CA2190858A1 (en) | Intermediate for preparing a pharmaceutically active compound | |
| MX9605794A (es) | Intermediario para preparar un compuesto farmaceuticamente activo. | |
| AU5932394A (en) | New compound, leustroducsin H, its preparation and its therapeutic use |